RBC Capital on Johnson & Johnson (JNJ): 'Icotrokinra's +$5B Opportunity is Progressing'

March 12, 2025 10:55 AM EDT Send to a Friend
RBC Capital analyst Shagun Singh reiterated an Outperform rating and $181.00 price target on Johnson & Johnson (NYSE: JNJ).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login